Abstract:Background The advancements in artificial intelligence and computational power have made deep learning an attractive tool for radiotherapy treatment planning. Deep learning has the potential to significantly simplify the trial‐and‐error process involved in inverse planning required by modern treatment techniques such as volumetric modulated arc therapy (VMAT). In this study, we explore the ability of deep learning to predict organ‐at‐risk (OAR) dose–volume histograms (DVHs) of left‐sided breast cancer patients undergoing VMAT treatment based solely on their anatomical characteristics. The predicted DVHs could be used to derive patient‐specific dose constraints and dose objectives, streamlining the treatment planning process, standardizing the quality of the plans, and personalizing the treatment planning. Purpose This study aimed to develop a deep learning‐based framework for the prediction of organ‐specific dose–volume histograms (DVH) based on structures delineated for left‐sided breast cancer treatment. Methods We used a dataset of 249 left‐sided breast cancer patients treated with tangential VMAT fields. We extracted delineated structures and dose distributions for each patient and derived slice‐by‐slice DVHs for planning target volume (PTV) and organs‐at‐risk. The patients were divided into training (70%, n = 174), validation (10%, n = 24), and test (20%, n = 51) sets. Collected data were used to train a deep learning model for the prediction of the DVHs based on the delineated structures. The developed deep learning model comprised a modified DenseNet architecture followed by a recurrent neural network. Results In the independent test set (n = 51), the point‐wise differences in the slice‐by‐slice DVHs between the clinical and predicted DVHs were small; the mean squared errors were 3.53, 1.58, 2.28, 3.37, and 1.44 [×10−4] for PTV, heart, ipsilateral lung, contralateral lung, and contralateral breast, respectively. With the derived cumulative DVHs, the mean absolute difference ± standard deviation of mean doses between the clinical and the predicted DVH were 0.08 ± 0.04 Gy, 0.24 ± 0.22 Gy, 0.73 ± 0.46 Gy, 0.07 ± 0.06 Gy, and 0.14 ± 0.14 Gy for PTV, heart, ipsilateral lung, contralateral lung, and contralateral breast, respectively. Conclusions The deep learning‐based approach enabled automatic and reliable prediction of the DVH based on delineated structures. The predicted DVHs could potentially serve as patient‐specific clinical goals used to aid treatment planning and avoid suboptimal plans or to derive optimization objectives and constraints for automated treatment planning.

Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment

Aleatoric and epistemic uncertainty extraction of patient-specific deep learning-based dose predictions in LDR prostate brachytherapy

Deep learning-based dose map prediction for high-dose-rate brachytherapy

Deep learning-based dose prediction for magnetic resonance-guided prostate radiotherapy

Deep learning‐based prediction of the dose–volume histograms for volumetric modulated arc therapy of left‐sided breast cancer

Technical Note: A feasibility study on deep learning-based radiotherapy dose calculation

Improving 3D dose prediction for breast radiotherapy using novel glowing masks and gradient-weighted loss functions

Large‐language‐model empowered 3D dose prediction for intensity‐modulated radiotherapy

A Feasibility Study on Deep Learning Based Individualized 3D Dose Distribution Prediction

Improvement of accumulated dose distribution in combined cervical cancer radiotherapy with deep learning-based dose prediction

A personalized DVH prediction model for HDR brachytherapy in cervical cancer treatment

Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers

A deep learning approach to radiation dose estimation

Deep learning prediction of scenario doses for direct plan robustness evaluations in IMPT for head-and-neck

Knowledge-Based Three-Dimensional Dose Prediction for Tandem-And-Ovoid Brachytherapy

Deep-learning-based Modulated Radiotherapy Dose Plan Prediction with Integration of Non-Modulated Dose Distribution

Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning

Deep learning reconstruction of digital breast tomosynthesis images for accurate breast density and patient-specific radiation dose estimation

Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans

A Feasibility Study on Deep Learning-Based Radiotherapy Dose Calculation

Deep Learning 3D Dose Prediction for Conventional Lung IMRT Using Consistent/Unbiased Automated Plans